Cerillion Full Year 2022 Earnings: Beats Expectations




  • In Business
  • 2022-11-30 05:06:56Z
  • By Simply Wall St.
 

Cerillion (LON:CER) Full Year 2022 Results

Key Financial Results

  • Revenue: UK£32.7m (up 26% from FY 2021).

  • Net income: UK£9.34m (up 45% from FY 2021).

  • Profit margin: 29% (up from 25% in FY 2021). The increase in margin was driven by higher revenue.

  • EPS: UK£0.32 (up from UK£0.22 in FY 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Cerillion Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 12%.

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 9.2% growth forecast for the Software industry in the United Kingdom.

Performance of the British Software industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Cerillion's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

Industry Analysts Just Upgraded Their 3i Group plc (LON:III) Revenue Forecasts By 63%
Industry Analysts Just Upgraded Their 3i Group plc (LON:III) Revenue Forecasts By 63%

3i Group plc ( LON:III ) shareholders will have a reason to smile today, with the analysts making substantial upgrades...

Broker Revenue Forecasts For Diaceutics PLC (LON:DXRX) Are Surging Higher
Broker Revenue Forecasts For Diaceutics PLC (LON:DXRX) Are Surging Higher

Diaceutics PLC ( LON:DXRX ) shareholders will have a reason to smile today, with the analysts making substantial...

Actual Experience Full Year 2022 Earnings: UK£0.092 loss per share (vs UK£0.11 loss in FY 2021)
Actual Experience Full Year 2022 Earnings: UK£0.092 loss per share (vs UK£0.11 loss in FY 2021)

Actual Experience ( LON:ACT ) Full Year 2022 Results Key Financial Results Revenue: UK£1.18m (down 32% from FY 2021...

Best of the Best
Best of the Best's (LON:BOTB) five-year earnings growth trails the stellar shareholder returns

Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...

Investors in MeVis Medical Solutions (ETR:M3V) have made a return of 27% over the past three years
Investors in MeVis Medical Solutions (ETR:M3V) have made a return of 27% over the past three years

One simple way to benefit from the stock market is to buy an index fund. But if you choose individual stocks with...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business